Double-blind, placebo-controlled trial to assess the efficacy and tolerability of mepartricin in the treatment of BPH
- 1 December 1998
- journal article
- clinical trial
- Published by Wiley in The Prostate
- Vol. 37 (4) , 246-252
- https://doi.org/10.1002/(sici)1097-0045(19981201)37:4<246::aid-pros6>3.0.co;2-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Placebo Controlled Double-blind Study to Test the Efficacy of the Aromatase Inhibitor Atamestane in Patients with Benign Prostatic Hyperplasia not Requiring OperationJournal of Urology, 1995
- Endocrine Environment of Benign Prostatic Hyperplasia: Prostate Size and Volume are Correlated with Serum Estrogen ConcentrationScandinavian Journal of Urology and Nephrology, 1995
- Benign prostatic hyperplasia:Effects on quality of life and impact on treatment decisionsUrology, 1994
- Urinary symptoms in the community: how bothersome are they?British Journal of Urology, 1994
- Influence of Age and Endocrine Factors on the Volume of Benign Prostatic HyperplasiaJournal of Urology, 1991
- Faecal Elimination of Steroids in Rats after Oral Administration of MepartricinJournal of International Medical Research, 1990
- Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistryThe Prostate, 1990
- The Development of Human Benign Prostatic Hyperplasia with AgeJournal of Urology, 1984
- Age Variation of the 24-Hour Mean Plasma Concentrations of Androgens, Estrogens, and Gonadotropins in Normal Adult Men*Journal of Clinical Endocrinology & Metabolism, 1982
- Partricin methyl ester, a semisynthetic polyene antibioticCellular and Molecular Life Sciences, 1972